IRIS
FERRAROTTI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.856
AS - Asia 2.253
EU - Europa 1.552
SA - Sud America 350
Continente sconosciuto - Info sul continente non disponibili 101
AF - Africa 94
OC - Oceania 1
Totale 7.207
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.780
CN - Cina 877
SG - Singapore 542
VN - Vietnam 305
HK - Hong Kong 288
BR - Brasile 264
IE - Irlanda 260
RU - Federazione Russa 233
IT - Italia 204
DE - Germania 199
FR - Francia 130
FI - Finlandia 120
GB - Regno Unito 114
UA - Ucraina 102
ZA - Sudafrica 59
SE - Svezia 57
IN - India 56
CA - Canada 44
BD - Bangladesh 40
AR - Argentina 28
NL - Olanda 23
BE - Belgio 19
IQ - Iraq 19
PL - Polonia 18
AT - Austria 17
MX - Messico 17
EC - Ecuador 16
TR - Turchia 15
PH - Filippine 13
CZ - Repubblica Ceca 12
ES - Italia 12
ID - Indonesia 12
JP - Giappone 12
PK - Pakistan 11
VE - Venezuela 11
CO - Colombia 10
UZ - Uzbekistan 9
CL - Cile 8
MA - Marocco 8
SA - Arabia Saudita 8
CH - Svizzera 7
LT - Lituania 7
PY - Paraguay 6
TN - Tunisia 6
JO - Giordania 5
KE - Kenya 5
LB - Libano 5
MY - Malesia 5
DK - Danimarca 4
HN - Honduras 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
ET - Etiopia 3
IL - Israele 3
MU - Mauritius 3
NP - Nepal 3
QA - Qatar 3
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
KR - Corea 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 7.105
Salva come PNG Salva come JPEG
Città #
San Jose 378
Singapore 279
Hong Kong 273
Ashburn 265
Dublin 260
Chandler 244
Dallas 215
Beijing 210
Nanjing 151
Council Bluffs 144
Jacksonville 100
Ho Chi Minh City 98
Boardman 88
Lauterbourg 84
Ann Arbor 78
Los Angeles 76
Hanoi 74
Redondo Beach 64
New York 63
Munich 61
Helsinki 60
Johannesburg 48
Lawrence 45
Medford 45
Princeton 45
Moscow 42
Nanchang 42
Dearborn 40
Shanghai 40
Wilmington 34
Shenyang 32
São Paulo 32
Changsha 31
Santa Clara 30
Buffalo 28
Houston 28
Turku 24
Jiaxing 23
Orem 23
Hebei 22
Frankfurt am Main 21
Columbus 20
Milan 20
Phoenix 20
Brussels 19
Da Nang 19
Toronto 19
Pavia 18
Tianjin 18
Nuremberg 17
Rome 17
The Dalles 17
Vinnytsia 17
Brooklyn 16
Amsterdam 15
Falkenstein 15
Hangzhou 15
Montesilvano Marina 15
Chicago 14
Chongqing 14
London 14
Piemonte 14
Warsaw 14
Woodbridge 14
Haiphong 12
Tokyo 12
Denver 11
Kunming 11
Stockholm 11
Montreal 10
Redwood City 10
Washington 10
Atlanta 9
Chennai 9
Vienna 9
Guangzhou 8
Norwalk 8
Poplar 8
Tashkent 8
Turin 8
Ankara 7
Basingstoke 7
Des Moines 7
Jinan 7
Baghdad 6
Biên Hòa 6
Düsseldorf 6
Fairfield 6
Hefei 6
Hyderabad 6
Hải Dương 6
New Delhi 6
Rio de Janeiro 6
Seattle 6
Zhengzhou 6
Belo Horizonte 5
Bologna 5
Brasília 5
Caracas 5
Charlotte 5
Totale 4.594
Salva come PNG Salva come JPEG
Nome #
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 202
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 146
Lyosecretome for use in the treatment of autoimmune diseases 143
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 139
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 139
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 137
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 136
Expression of receptor for advanced glycation end products in sarcoid granulomas. 121
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 119
A regulatory SNP in the Promoter Region of the RAGE Gene 118
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 118
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 115
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 114
Identification and characterisation of eight novel SERPINA1 null mutations. 114
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 113
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 111
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 109
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 108
Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD 108
Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease 105
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 103
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. 102
Alpha-1 antitrypsin deficiency: From the lung to the heart? 101
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 99
α₁-Antitrypsin level and pheno/genotypes 99
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 99
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 98
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 97
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 94
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 94
COPD: no gene left unturned 90
An Italian expert consensus on the management of alpha1-antitrypsin deficiency: a comprehensive set of algorithms 89
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. 89
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review 88
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 88
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 86
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 85
The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency 84
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 84
Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology 82
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 82
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 82
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency 80
Practical dietary advices for subjects with alpha-1 antitrypsin deficiency 78
Immune Activation in alpha(1)-Antitrypsin-Deficiency Emphysema Beyond the Protease-Antiprotease Paradigm 75
The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization. 75
Update on α1-antitrypsin deficiency 72
Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency 71
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale 70
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 70
Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: Enough is enough 70
Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency 69
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 69
Kruppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. 66
Improving the diagnosis of AATD with aid of serum protein electrophoresis: A prospective, multicentre, validation study 65
Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency. 65
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 64
Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency 63
α1-Antitrypsin deficiency. 62
Place of genotyping and phenotype in addition to the assay of serum α -1 antitrypsin 61
Recommendations for the measurement of the most important plasma proteins 61
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 59
Alpha-1 antitrypsin deficiency is significantly associated with atopy in asthmatic patients 59
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. 59
Sanger and Next-Generation Sequencing of AAT 57
Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes 56
Alpha1-antitrypsin deficiency in Greece: Focus on rare variants 55
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 55
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. 55
Clinical manifestations in patients with PI*MMMalton genotypes. A matter still unsolved in alpha-1 antitrypsin deficiency 53
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 53
Complement receptor 1 gene polymorphisms in sarcoidosis. 50
Air Trapping Is Associated with Heterozygosity for Alpha-1 Antitrypsin Mutations in Patients with Asthma 50
How can we improve the detection of Alpha1-antitrypsin deficiency? 48
Protocol for the earco registry: A pan-european observational study in patients with α1-antitrypsin deficiency 45
SERPINA1 gene variants in individuals from the general population with reduced ?1-antitrypsin concentrations 44
Long-term effect of α1-antitrypsin augmentation therapy on the decline of fev1 in deficient patients: An analysis of the air database 42
Alpha-1 antitrypsin screening in a selected cohort of patients affected by chronic pulmonary diseases in Naples, Italy 42
Effect of α1 antitrypsin deficiency on lung volume decline in severe asthmatic patients undergoing biologic therapy 42
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 41
Transplant with MZ genotype liver: what is the clinical pulmonary picture after 30 years? a case report and review of the literature 40
The importance of n186 in the alpha-1-antitrypsin shutter region is revealed by the novel bologna deficiency variant 37
What is the knowledge on alpha-1 antitrypsin deficiency among Italian pulmonologists? 37
Phenotypic Expression of Respiratory Diseases and Tailored Treatment in Patients with Intermediate Alpha-1 Antitrypsin Deficiency: Evidence from a Retrospective Analysis of a Selected Cohort of Patients 37
Research priorities in α1-antitrypsin deficiency: Results of a patients’ and healthcare providers’ international survey from the earco clinical research collaboration 34
New patient-centric approaches to the management of alpha-1 antitrypsin deficiency 34
Diagnosis and treatment of pulmonarydisease in alfa-1-antitrypsin deficiency: A statement of European Respiratory Society 33
Investigating the Link between Alpha-1 Antitrypsin Deficiency and Abdominal Aortic Aneurysms 33
Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants 30
Alpha-1 antitrypsin deficiency-associated liver disease: A review focusing on new assessment tools and therapies 29
PI*ZQ0Attikon genotype discovery in severe alpha-1 antitrypsin deficiency 25
The phenotypic state of bi allelic SERPINA1 Q0 variants in alpha-1 antitrypsin deficiency 25
Performance of enhanced liver fibrosis test and indirect serum fibrosis markers for exclusion of advanced liver fibrosis in alpha-1 antitrypsin deficiency 12
Totale 7.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.440
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022193 0 2 4 5 1 2 5 16 13 4 28 113
2022/2023712 85 49 6 44 82 68 3 30 308 7 20 10
2023/2024395 26 75 16 10 35 98 11 20 2 53 27 22
2024/20251.476 20 71 76 90 30 134 57 80 329 70 185 334
2025/20263.159 235 200 322 348 379 158 670 118 317 231 116 65
2026/2027248 74 174 0 0 0 0 0 0 0 0 0 0
Totale 7.207